Literature DB >> 14742521

Salivary statherin peptide-binding epitopes of commensal and potentially infectious Actinomyces spp. delineated by a hybrid peptide construct.

Liza Danielsson Niemi1, Ingegerd Johansson.   

Abstract

Adhesion of microorganisms to host receptor molecules such as salivary statherin molecules is a common event in oral microbial colonization. Here we used a hybrid peptide construct (with both a hydroxyapatite-binding portion and a test peptide portion) to map the interaction of Actinomyces species (and Candida albicans) with statherin. Adhesion to hybrid peptides and truncated statherin variants revealed three binding types, types I to III. (i) Type I strains of rat, hamster, and human infection origins bound C-terminal-derived QQYTF and PYQPQY peptides. The QQYTF peptide inhibited statherin binding for some strains but not for others. (ii) Type II strains of human and monkey tooth origins bound middle-region-derived YQPVPE and QPLYPQ peptides. Neither strain was inhibited by soluble peptides. (iii) Type III strains of human infection origins (and C. albicans) did not bind to either statherin-derived peptides or truncated statherin. Moreover, the type I strains inhibited by QQYTF were also inhibited by TF and QAATF peptides and were detached from statherin by the same peptides. In conclusion, it is suggested that commensal and potentially infectious microorganisms bind middle or C-terminal statherin differently and that other microbes might require discontinuous epitopes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14742521      PMCID: PMC321590          DOI: 10.1128/IAI.72.2.782-787.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

Review 1.  Actinomycosis.

Authors:  R A Smego; G Foglia
Journal:  Clin Infect Dis       Date:  1998-06       Impact factor: 9.079

2.  Binding sites of salivary statherin for Porphyromonas gingivalis recombinant fimbrillin.

Authors:  A Amano; K Kataoka; P A Raj; R J Genco; S Shizukuishi
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

3.  Statherin and the proline-rich parotid proteins PRP II and PRP IV as amino nitrogen sources for plaque-forming oral streptococci.

Authors:  R A Cowman; S J Schaefer; F P Oppenheim; D I Hay
Journal:  J Dent Res       Date:  1979-10       Impact factor: 6.116

4.  Characterization of low-molecular-weight peptides in human parotid saliva.

Authors:  H E Perinpanayagam; B C Van Wuyckhuyse; Z S Ji; L A Tabak
Journal:  J Dent Res       Date:  1995-01       Impact factor: 6.116

5.  The isolation of Actinomyces naeslundii from sound root surfaces and root carious lesions.

Authors:  S R Brailsford; E Lynch; D Beighton
Journal:  Caries Res       Date:  1998       Impact factor: 4.056

6.  Oligosaccharide-receptor interaction of the Gal alpha 1-4Gal binding adhesin of Streptococcus suis. Combining site architecture and characterization of two variant adhesin specificities.

Authors:  S Haataja; K Tikkanen; U Nilsson; G Magnusson; K A Karlsson; J Finne
Journal:  J Biol Chem       Date:  1994-11-04       Impact factor: 5.157

7.  Actinomyces naeslundii displays variant fimP and fimA fimbrial subunit genes corresponding to different types of acidic proline-rich protein and beta-linked galactosamine binding specificity.

Authors:  K Hallberg; C Holm; U Ohman; N Strömberg
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

8.  Distinct mechanisms of epithelial adhesion for Candida albicans and Candida tropicalis. Identification of the participating ligands and development of inhibitory peptides.

Authors:  C M Bendel; M K Hostetter
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

9.  Nucleotide sequence analysis of the human salivary protein genes HIS1 and HIS2, and evolution of the STATH/HIS gene family.

Authors:  L M Sabatini; T Ota; E A Azen
Journal:  Mol Biol Evol       Date:  1993-05       Impact factor: 16.240

10.  Delineation of a segment of adsorbed salivary acidic proline-rich proteins which promotes adhesion of Streptococcus gordonii to apatitic surfaces.

Authors:  R J Gibbons; D I Hay; D H Schlesinger
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

View more
  6 in total

1.  Adsorption of follicular dendritic cell-secreted protein (FDC-SP) onto mineral deposits. Application of a new stable gene expression system.

Authors:  Tamayuki Shinomura; Sayaka Nakamura; Kazuo Ito; Shin-ichi Shirasawa; Magnus Höök; James H Kimura
Journal:  J Biol Chem       Date:  2008-09-19       Impact factor: 5.157

2.  Mass spectrometric identification of key proteolytic cleavage sites in statherin affecting mineral homeostasis and bacterial binding domains.

Authors:  Eva J Helmerhorst; Georges Traboulsi; Erdjan Salih; Frank G Oppenheim
Journal:  J Proteome Res       Date:  2010-10-01       Impact factor: 4.466

3.  Respiratory epithelial gene expression in patients with mild and severe cystic fibrosis lung disease.

Authors:  Jerry M Wright; Christian A Merlo; Jeffrey B Reynolds; Pamela L Zeitlin; Joe G N Garcia; William B Guggino; Michael P Boyle
Journal:  Am J Respir Cell Mol Biol       Date:  2006-04-13       Impact factor: 6.914

4.  Fusobacterium nucleatum envelope protein FomA is immunogenic and binds to the salivary statherin-derived peptide.

Authors:  Hidetaka Nakagaki; Shinichi Sekine; Yutaka Terao; Masahiro Toe; Muneo Tanaka; Hiro-O Ito; Shigetada Kawabata; Satoshi Shizukuishi; Kohtaro Fujihashi; Kosuke Kataoka
Journal:  Infect Immun       Date:  2009-12-14       Impact factor: 3.441

Review 5.  Deleted in malignant brain tumors-1 protein (DMBT1): a pattern recognition receptor with multiple binding sites.

Authors:  Antoon J M Ligtenberg; Niclas G Karlsson; Enno C I Veerman
Journal:  Int J Mol Sci       Date:  2010-12-17       Impact factor: 5.923

6.  Identification of key genes and pathways in chronic rhinosinusitis with nasal polyps and asthma comorbidity using bioinformatics approaches.

Authors:  Mingming Wang; Shuangmei Tang; Xiaoqi Yang; Xinyu Xie; Yang Luo; Shaojuan He; Xuezhong Li; Xin Feng
Journal:  Front Immunol       Date:  2022-08-17       Impact factor: 8.786

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.